Literature DB >> 11161074

New insights into atherosclerotic plaque rupture.

D M Braganza1, M R Bennett.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11161074      PMCID: PMC1741926          DOI: 10.1136/pmj.77.904.94

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  58 in total

1.  Microscopic localization of active proteases by in situ zymography: detection of matrix metalloproteinase activity in vascular tissue.

Authors:  Z S Galis; G K Sukhova; P Libby
Journal:  FASEB J       Date:  1995-07       Impact factor: 5.191

Review 2.  Molecular bases of the acute coronary syndromes.

Authors:  P Libby
Journal:  Circulation       Date:  1995-06-01       Impact factor: 29.690

3.  Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques.

Authors:  M R Bennett; G I Evan; S M Schwartz
Journal:  J Clin Invest       Date:  1995-05       Impact factor: 14.808

4.  Biphasic pattern of cell turnover characterizes the progression from fatty streaks to ruptured human atherosclerotic plaques.

Authors:  E Lutgens; E D de Muinck; P J Kitslaar; J H Tordoir; H J Wellens; M J Daemen
Journal:  Cardiovasc Res       Date:  1999-02       Impact factor: 10.787

5.  Probucol inhibits not only the progression of atherosclerotic disease, but causes a different composition of atherosclerotic lesions in WHHL-rabbits.

Authors:  J H Braesen; U Beisiegel; A Niendorf
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

6.  Apoptosis in human atherosclerosis and restenosis.

Authors:  J M Isner; M Kearney; S Bortman; J Passeri
Journal:  Circulation       Date:  1995-06-01       Impact factor: 29.690

7.  Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases.

Authors:  Z S Galis; G K Sukhova; R Kranzhöfer; S Clark; P Libby
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-17       Impact factor: 11.205

8.  Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques.

Authors:  Z S Galis; G K Sukhova; M W Lark; P Libby
Journal:  J Clin Invest       Date:  1994-12       Impact factor: 14.808

9.  Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: a role for apoptosis in plaque thrombogenicity.

Authors:  Z Mallat; B Hugel; J Ohan; G Lesèche; J M Freyssinet; A Tedgui
Journal:  Circulation       Date:  1999-01-26       Impact factor: 29.690

10.  Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels. The Regression Growth Evaluation Statin Study (REGRESS).

Authors:  J W Jukema; A V Bruschke; A J van Boven; J H Reiber; E T Bal; A H Zwinderman; H Jansen; G J Boerma; F M van Rappard; K I Lie
Journal:  Circulation       Date:  1995-05-15       Impact factor: 29.690

View more
  12 in total

Review 1.  Critical review of unstable angina and non-ST elevation myocardial infarction.

Authors:  P J Sheridan; D C Crossman
Journal:  Postgrad Med J       Date:  2002-12       Impact factor: 2.401

2.  Hyperlipemia and oxidation of LDL induce vascular smooth muscle cell growth: an effect mediated by the HLH factor Id3.

Authors:  Angela M Taylor; Feng Li; Pushpa Thimmalapura; Ross G Gerrity; Ian J Sarembock; Scott Forrest; Sarah Rutherford; Coleen A McNamara
Journal:  J Vasc Res       Date:  2005-12-07       Impact factor: 1.934

Review 3.  Atheromas feel the pressure: biomechanical stress and atherosclerosis.

Authors:  Amy L Pyle; Pampee P Young
Journal:  Am J Pathol       Date:  2010-06-17       Impact factor: 4.307

Review 4.  The Prospective Application of Melatonin in Treating Epigenetic Dysfunctional Diseases.

Authors:  Seth Mikaye Monayo; Xin Liu
Journal:  Front Pharmacol       Date:  2022-05-20       Impact factor: 5.988

5.  Statins as first-line therapy for acute coronary syndrome?

Authors:  Petr Ostadal
Journal:  Exp Clin Cardiol       Date:  2012

Review 6.  Review and meta-analysis of epidemiological associations between low/moderate doses of ionizing radiation and circulatory disease risks, and their possible mechanisms.

Authors:  M P Little; E J Tawn; I Tzoulaki; R Wakeford; G Hildebrandt; F Paris; S Tapio; P Elliott
Journal:  Radiat Environ Biophys       Date:  2009-10-28       Impact factor: 1.925

7.  Matrix metalloproteinase-3 (MMP-3) -1612 5A/6A promoter polymorphism in coronary artery disease in Indian population.

Authors:  Kavita K Shalia; V K Shah; M R Mashru; S L Soneji; J B Vasvani; S Payannavar; A Walvalkar; R Mokal; S S Mithbawkar; M Bootwalla; P Sadvekar; P K Thakur
Journal:  Indian J Clin Biochem       Date:  2010-05-27

Review 8.  Do non-targeted effects increase or decrease low dose risk in relation to the linear-non-threshold (LNT) model?

Authors:  M P Little
Journal:  Mutat Res       Date:  2010-01-25       Impact factor: 2.433

9.  Plaque regression and plaque stabilisation in cardiovascular diseases.

Authors:  Tarun Dave; J Ezhilan; Hardik Vasnawala; Vinod Somani
Journal:  Indian J Endocrinol Metab       Date:  2013-11

10.  A model of cardiovascular disease giving a plausible mechanism for the effect of fractionated low-dose ionizing radiation exposure.

Authors:  Mark P Little; Anna Gola; Ioanna Tzoulaki
Journal:  PLoS Comput Biol       Date:  2009-10-23       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.